SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Marcus Jorge Oslan who wrote (147)12/2/1996 10:47:00 PM
From: I. Luttichuys   of 1762
 
Hello Marcus,
I refer to Joyce Lonergan of Cowen & Co. who covered the release of Phase II for CE9.1 (Rheumatoid Arthritis therapy) on or about Oct. 21st. Her report contained errors and I feel this didn't help matters for us as far as the subsequent stock movement was concerned. You can see reply #85 on this thread for a more thorough re-cap of those events.
As to your second question, I am a bit hesitant to say stock may reach 32 BY DEC. 6. Historically, however, I think we could touch that valuation shortly after the 6th. (I'm putting my head out here)
The Phase II on this one pushed the stock up about $10 if I remember correctly. On the other hand I find myself wondering lately if the steep rise of the last 12 or so days could lead the market to perceive that positive Phase III is already somewhat priced into the stock by Dec. 6th. I don't really believe that, but I thought I'd tell you that the thought crosses my mind.
To ask if we might see 32 by Dec. 6th is pretty precise as you know so I invite anyone else on the thread to give an opinion.
If you were positioned such that reaching 30 by, say, mid to late December were important, you may just make it.

Have a good evening,
BENNETT
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News